DVA vs NAGE · P/E 14, rev $6.97B vs P/E 59, rev $61.3M
DaVita HealthCare Partners Inc (DVA) versus Niagen Bioscience, Inc. (NAGE) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Latest reported DVA revenue for 2026-06-30 was $6.97B. Net income was $462.9M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Not investment advice. Open the DVA and NAGE stock pages for the full models.
Not investment advice.